Sarepta Therapeutics Inc.

In News

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - businesswire.com

businesswire.com - Mar 31, 2026

Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1 - Sarepta Therapeutics

Sarepta Therapeutics - Mar 25, 2026

Sarepta Therapeutics shares rise on early promise for rare disease drugs - statnews.com

statnews.com - Mar 25, 2026

Why Is Sarepta Therapeutics (SRPT) Up 24.2% Since Last Earnings Report? - Yahoo Finance

Yahoo Finance - Mar 27, 2026

Sarepta Therapeutics - It's Too Early To Get Excited About siRNA Data (NASDAQ:SRPT) - Seeking Alpha

Seeking Alpha - Mar 26, 2026

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

MarketBeat - Mar 27, 2026

Sarepta Pushes Past Gene Therapy Debacle as RNA Therapies Show Early Promise - BioSpace

BioSpace - Mar 26, 2026

Sarepta Provides Regulatory Update on AMONDYS 45® and VYONDYS 53® - Sarepta Therapeutics

Sarepta Therapeutics - Mar 19, 2026

Mirador Capital Partners LP Invests $3.01 Million in Sarepta Therapeutics, Inc. $SRPT - MarketBeat

MarketBeat - Mar 28, 2026

Sarepta Therapeutics, Inc. (SRPT) Discusses Preliminary Phase I/II Data for SRP-1001 in FSHD1 and SRP-1003 in DM1 - Slideshow (NASDAQ:SRPT) 2026-03-25 - Seeking Alpha

Seeking Alpha - Mar 25, 2026

Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory - Yahoo Finance

Yahoo Finance - Feb 28, 2026

Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Developments - Sarepta Therapeutics

Sarepta Therapeutics - Feb 25, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment